Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nykode Therapeutics ASA
NYKDCurrent price
2.17 NOK
-0.032 NOK (-1.45%)
Last closed
2.13 NOK
Company
nykode.com
ISIN
NO0010714785
Sector
Healthcare
Industry
Biotechnology
Exchange
Oslo Stock Exchange
Capitalization
793 580 788 NOK
Yield for 12 month
-88.20 %
1Y
3Y
5Y
10Y
15Y
NYKD
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway. Address: Oslo Research Park, Oslo, Norway, 0349
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
22.77 NOKP/E ratio
–Dividend Yield
–Current Year
+144 022 936 NOK
Last Year
+80 015 223 NOK
Current Quarter
+6 072 584 NOK
Last Quarter
+9 231 667 NOK
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures NYKD
1 year
3 years
5 years
10 years
EBITDA
-58 873 254 NOK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-19.95 %
PEG Ratio
–
Return On Equity TTM
-25.99 %
Wall Street Target Price
22.77 NOK
Revenue TTM
6 598 065 NOK
Book Value
0.47 NOK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-88.5 %
Dividend Yield
–
Gross Profit TTM
9 142 715 NOK
Earnings per share
-1.35 NOK
Diluted Eps TTM
-1.35 NOK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-93.5 %
Profit Margin
–
Dividend Analytics NYKD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NYKD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NYKD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.89
Price Sales TTM
120.2748
Enterprise Value EBITDA
-332.2438
Price Book MRQ
0.4644
Financials NYKD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NYKD
For 52 weeks
1.57 NOK
21.89 NOK
50 Day MA
5.04 NOK
Shares Short Prior Month
–
200 Day MA
12.15 NOK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart